Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Seoul National University Bundang Hospital
Azienda Ospedaliero-Universitaria di Parma
Ocellaris Pharma, Inc.
Mayo Clinic
Universitair Ziekenhuis Brussel
TScan Therapeutics, Inc.
University of Pittsburgh
AVM Biotechnology Inc
Bicara Therapeutics
Leap Therapeutics, Inc.
Numab Therapeutics AG
Revolution Medicines, Inc.
UNICANCER
The Center for Clinical and Cosmetic Research
Carisma Therapeutics Inc
The Center for Clinical and Cosmetic Research
Advaxis, Inc.
Pfizer
Charite University, Berlin, Germany
Umeå University
Revolution Medicines, Inc.
Fate Therapeutics
Institut de Cancérologie de Lorraine
Revolution Medicines, Inc.
University Health Network, Toronto
University of South Alabama
University Health Network, Toronto
SpeciCare
Ontario Clinical Oncology Group (OCOG)
University of California, San Diego
The University of Texas Medical Branch, Galveston
Gloucestershire Hospitals NHS Foundation Trust
Memorial Sloan Kettering Cancer Center
Emory University
Memorial Sloan Kettering Cancer Center
Tufts Medical Center
UNICANCER